Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Portal Hypertension
Questions discussed in this category
What patient clinical factors do you find most impact a patient's "beta-blocker window" and their ability to maintain and tolerate beta-blocker therapy?
1 Answer available
When would you choose to measure a patient's spleen stiffness?
What are you looking for that would impact your management of a patient?
2 Answers available
What clinical evidence do you find most favorable of a positive response post-liver transplant for patients with portopulmonary hypertension?
1 Answer available
What clinical scenario would you favor NOT using terlipressin for the management of HRS if there were no notable contraindications for its initiation?
1 Answer available
What is your approach to the management of post-TIPS hepatic encephalopathy?
1 Answer available
Would you consider sotalol to be a suitable non-selective beta blocker for primary prevention of variceal bleeding in a patient who requires sotalol for treatment of arrhythmia in the setting of Fontan-associated liver disease and clinically significant portal hypertension?
1 Answer available
Which patients with cirrhosis and portal hypertension are ideal candidates to undergo TIPS to reduce perioperative risk in anticipation of an elective surgery?
1 Answer available
How do you determine the optimal time to restart a diuretic in a patient with cirrhosis, ascites, and lower extremity edema who presented with acute kidney injury that resolved with IV albumin and holding diuretics?
1 Answer available
Do you still consider hepatorenal syndrome in patients with renal impairment and liver disease who are found to have rare muddy brown casts on urine microscopy?
1 Answer available
Would you recommend a TIPS procedure in the management of hepatorenal syndrome for a patient with no history of hepatic encephalopathy?
1 Answer available
How do you manage patients with end stage kidney disease and recurrent ascites who do not have any evidence of cardiac or liver disease?
3 Answers available
Do you recommend giving IV albumin with furosemide to augment diuresis in a patient with hypoalbuminemia and volume overload?
1 Answer available
How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?
2 Answers available
How can hepatic venous pressure gradients in patients with cirrhosis be used to differentiate between cardiac cirrhosis and portopulmonary hypertension?
In which clinical scenario(s) would you consider checking HVPG?
3 Answers available
To what extent does the degree of thrombocytopenia correlate with the severity of cirrhosis?
1 Answer available
What is your preferred anticoagulant for acute portal vein thrombosis?
How does cirrhosis and/or underlying thrombophilia affect your decision?
1 Answer available
What is your standard workup and treatment for an incidentally-noted splanchnic vein thrombosis?
What is your duration of anticoagulation?
1 Answer available
23689
23547
23685
23686
23688
22250
21601
21731
19047
16534
17479
19320
17674
15330
12751
10958
10978
Papers discussed in this category
Blood, 2014 Oct 15
How I treat splanchnic vein thrombosis.
Lancet (London, England), 2019 Mar 22
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Related Topics
Hepatology
General Hepatology
Nephrology
General Internal Medicine
Hematology
Benign Hematology
Gastroenterology
Thrombosis
Acute kidney injury
Hospital Medicine